|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 1/18 | |
| A61K 39/00 |
| (11) | Patento numeris | 3068791 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14798760.6 |
| Europos patento paraiškos padavimo data | 2014-11-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/073986 |
| Data | 2014-11-06 |
| (87) | Numeris | WO 2015/071177 |
| Data | 2015-05-21 |
| (30) | Numeris | Data | Šalis |
| 201361904747 P | 2013-11-15 | US |
| (72) |
NORMAN, Carnley, US
SUDA, Eric, US
DOWLESS, Kayla, US
ASTIGARRAGA, Ruiz, US
BASTEK, Patrick, US
YANNONE, Vaishali, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | REMOVAL OF RESIDUAL CELL CULTURE IMPURITIES |
| REMOVAL OF RESIDUAL CELL CULTURE IMPURITIES |